市場調查報告書

精密醫療的全球市場:各技術、各用途、各終端用戶、各地區的預測和機會

Global Precision Medicine Market By Technology, By Applications, By End User, By Region, Forecast & Opportunities, 2025

出版商 TechSci Research 商品編碼 934729
出版日期 內容資訊 英文 120 Pages
商品交期: 請詢問到貨日
價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

精密醫療的全球市場:各技術、各用途、各終端用戶、各地區的預測和機會 Global Precision Medicine Market By Technology, By Applications, By End User, By Region, Forecast & Opportunities, 2025
出版日期: 2020年05月01日內容資訊: 英文 120 Pages
簡介

精密醫療,是提供各個患者最適合醫療的技術,用於循環系統疾病,腫瘤,呼吸疾病,免疫疾病等各種疾病的治療。市場擴大的原動力,是印度和中國等新興國家的人口增加和全世界的癌症患者增加,以腫瘤治療的領域為中心預測到2025年以2位數的年複合成長率繼續成長。

本報告提供全球精密醫療市場調查,新型冠狀病毒感染疾病(COVID-19)對市場產生的影響,各地區市場展望,市場力學與趨勢,競爭情形和主要企業的簡介等資訊,同時再加上策略性建議。

目錄

第1章 產品概要

第2章 調查方法

第3章 COVID-19對全球精密醫療市場的影響

第4章 客戶的迴響

第5章 摘要整理

第6章 全球市場的展望

  • 市場規模與預測
    • 以金額為準和以數量為準
  • 市場佔有率與預測
    • 各技術(人工智慧,全基因序列,搭配診斷,基因序列,巨量資料分析,分子影像,數位PCR,微陣列,CRISPR等)
    • 各用途(循環系統疾病,腫瘤,呼吸疾病,免疫疾病,其他)
    • 各終端用戶(製藥公司和生物科技企業,臨床研究組織、 研究機關,診斷相關的企業、 醫療IT相關的企業)
    • 各企業(2019年)
    • 各地區
  • 市場魅力指數

第7章 亞太地區市場展望

  • 市場規模與預測
    • 以金額為準和以數量為準
  • 市場佔有率與預測
    • 各技術
    • 各用途
    • 各終端用戶
    • 各國
  • 市場魅力指數
  • 亞太地區:各國分析
    • 中國
    • 印度
    • 日本
    • 韓國
    • 新加坡
    • 澳洲

第8章 歐洲的精密醫學的市場展望

  • 市場規模與預測
    • 以金額為準和以數量為準
  • 市場佔有率與預測
    • 各技術
    • 各用途
    • 各終端用戶
    • 各國
  • 市場魅力指數
  • 歐洲:各國分析
    • 法國
    • 德國
    • 英國
    • 義大利

第9章 北美市場展望

  • 市場規模與預測
    • 以金額為準和以數量為準
  • 市場佔有率與預測
    • 各技術
    • 各用途
    • 各終端用戶
    • 各國
  • 市場魅力指數
  • 北美:各國分析
    • 美國
    • 墨西哥
    • 加拿大

第10章 南美市場展望

  • 市場規模與預測
    • 以金額為準和以數量為準
  • 市場佔有率與預測
    • 各技術
    • 各用途
    • 各終端用戶
    • 各國
  • 市場魅力指數
  • 南美:各國分析
    • 巴西
    • 阿根廷
    • 哥倫比亞

第11章 中東、非洲市場展望

  • 市場規模與預測
    • 以金額為準和以數量為準
  • 市場佔有率與預測
    • 各技術
    • 各用途
    • 各終端用戶
    • 各國
  • 市場魅力指數
  • 中東、非洲:各國分析
    • 南非
    • 沙烏地阿拉伯
    • UAE

第12章 市場力學

  • 成長促進因素
  • 課題

第13章 市場趨勢

第14章 競爭情形

  • 競爭情形的展望
  • 主要企業的簡介
    • Orion Health
    • 2b Precise
    • Fabric Genomics
    • Pfizer
    • Gene
    • IBM Watson Health
    • Philips Healthcare
    • Medtronic
    • Nanthealth
    • Navican
    • N-of-One
    • PierianDx
    • Sunquest Information System
    • Tempus
    • Novartis
    • Translational Software
    • Biocrates Life Sciences AG
    • Nanostring Technologies
    • Thermo Fisher Scientific
    • Quest Diagnostics Incorporated

第15章 策略性建議

第16章 免責聲明

目錄
Product Code: 4684

As on date of publishing, this report will capture the impact assessment of COVID-19 on this market and the same will be considered in our market forecast model. Clients purchasing this report between April and June 2020 will be getting a 'free' updated market data excel sheet between July and September 2020 accounting for the impact of COVID-19 on the market in the current year 2020 and forecast.

Global precision medicine market is expected to grow at a double digit CAGR during the forecast period. Precision medicines are patient specific and vary from individual to individual. Increasing population and rising cancer cases in developing countries like India and China are the major factors propelling the growth of the precision medicine market. However, high price of precision medicines might hamper the growth of the market.

The global precision medicine market is segmented based on technology, application, end user, and region. The application segment is further divided into cardiology, oncology, respiratory, immunology and others. In 2019, oncology segment dominated the market and the trend is likely to continue in the coming years as well because of increasing cancer cases all over world.

In terms of regional analysis, market can be segregated into Asia-Pacific, North America, South America, Middle East & Africa and Europe. Among these, North America dominated the global precision medicine market until 2019 due to growing adoption of next generation sequencing methods in addition to favorable government policies. Additionally, Asia-Pacific is anticipated to grow at the fastest CAGR due to the rising cases of cancer and other fatal diseases in the developing economies like India and China.

Major players in the global precision medicine market include Orion Health, 2b Precise, Fabric Genomics, Pfizer, Gene 42, IBM Watson Health, Phillips Healthcare, Medtronic, Nanthealth, Navican, N-of-One, PierianDx, Sunquest Information System, Tempus, Novartis, Translational Software, Biocrates Life Sciences AG, Nanostring Technologies, Thermo Fisher Scientific, Quest Diagnostics Incorporate, etc. The companies are adopting various organic and inorganic strategies like, product launches, acquisitions and mergers to strengthen their position in the market.

Years considered for this report:

Historical Years: 2015-2018

Base Year: 2019

Estimated Year: 2020

Forecast Period: 2021-2025

Objective of the Study

  • To analyze and forecast the market size of global precision medicine market.
  • To classify and forecast global precision medicine market based on technology, application, end user, and region.
  • To identify drivers and challenges for global precision medicine market.
  • To examine competitive developments such as expansions, new product launches, mergers & acquisitions, etc., in global precision medicine market.
  • To conduct pricing analysis for global precision medicine market.
  • To identify and analyze the profile of leading players operating in global precision medicine market.

TechSci Research performed both primary as well as exhaustive secondary research for this study. Initially, TechSci Research sourced a list of manufacturers across the globe. Subsequently, TechSci Research conducted primary research surveys with the identified companies. While interviewing, the respondents were also enquired about their competitors. Through this technique, TechSci Research could include the manufacturers which could not be identified due to the limitations of secondary research. TechSci Research analyzed the manufacturers, distribution channels and presence of all major players across the globe.

TechSci Research calculated the market size of global precision medicine market using a bottom-up approach, wherein data for various end-user segments was recorded and forecast for the future years. TechSci Research sourced these values from the industry experts and company representatives and externally validated through analyzing historical data of these product types and applications for getting an appropriate, overall market size. Various secondary sources such as company websites, news articles, press releases, company annual reports, investor presentations and financial reports were also studied by TechSci Research.

Key Target Audience

  • Precision medicine manufacturers, suppliers, distributers and other stakeholders
  • Government bodies such as regulating authorities and policy makers
  • Organizations, forums and alliances related to precision medicine
  • Market research and consulting firms

The study is useful in providing answers to several critical questions that are important for the industry stakeholders such as manufacturers, partners, end users, etc., besides allowing them in strategizing investments and capitalizing on market opportunities.

Report Scope

In this report, global precision medicine market has been segmented into following categories, in addition to the industry trends which have also been detailed below:

  • Market, By Technology:

Artificial Intelligence

Whole Genome Sequencing

Companion Diagnostics

Genome Sequencing

Big Data Analytics

Molecular Imaging

Digital PCR

Microarray

CRISPR

Others

  • Market, By Application:

Cardiology

Oncology

Respiratory

Immunology

Others

  • Market, By End User:

Pharmaceutical and Biotechnology Companies

Clinical research organization

Research institutes

Diagnostic Companies

Healthcare IT

  • Market, By Region:

Asia-Pacific

  • China
  • India
  • Japan
  • South Korea
  • Singapore
  • Australia

Europe

  • France
  • Germany
  • United Kingdom
  • Italy

North America

  • United States
  • Mexico
  • Canada

South America

  • Brazil
  • Argentina
  • Colombia

Middle East & Africa

  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in global precision medicine market.

Available Customizations

With the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

2. Research Methodology

3. Impact of COVID-19 on Global Precision Medicine Market

4. Voice of Customer

5. Executive Summary

6. Global Precision Medicine Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value & Volume
  • 6.2. Market Share & Forecast
    • 6.2.1. By Technology (Artificial Intelligence, Whole Genome Sequencing, Companion Diagnostics, Genome Sequencing, Big Data Analytics, Molecular Imaging, Digital PCR, Microarray, CRISPR and Others)
    • 6.2.2. By Applications (Cardiology, Oncology, Respiratory, Immunology and Others)
    • 6.2.3. By End-User (Pharmaceutical and Biotechnology Companies, Clinical research organization, Research institutes, Diagnostic Companies, Healthcare IT)
    • 6.2.4. By Company (2019)
    • 6.2.5. By Region
  • 6.3. Market Attractiveness Index

7. Asia-Pacific Precision Medicine Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value & Volume
  • 7.2. Market Share & Forecast
    • 7.2.1. By Technology
    • 7.2.2. By Application
    • 7.2.3. By End-User
    • 7.2.4. By Country
  • 7.3. Market Attractiveness Index
  • 7.4. Asia-Pacific: Country Analysis
    • 7.4.1. China Precision Medicine Market Outlook
      • 7.4.1.1. Market Size & Forecast
        • 7.4.1.1.1. By Value
      • 7.4.1.2. Market Share & Forecast
        • 7.4.1.2.1. By Technology
        • 7.4.1.2.2. By Application
        • 7.4.1.2.3. By End-User
    • 7.4.2. India Precision Medicine Market Outlook
      • 7.4.2.1. Market Size & Forecast
        • 7.4.2.1.1. By Value
      • 7.4.2.2. Market Share & Forecast
        • 7.4.2.2.1. By Technology
        • 7.4.2.2.2. By Application
        • 7.4.2.2.3. By End-User
    • 7.4.3. Japan Precision Medicine Market Outlook
      • 7.4.3.1. Market Size & Forecast
        • 7.4.3.1.1. By Value
      • 7.4.3.2. Market Share & Forecast
        • 7.4.3.2.1. By Technology
        • 7.4.3.2.2. By Application
        • 7.4.3.2.3. By End-User
    • 7.4.4. South Korea Precision Medicine Market Outlook
      • 7.4.4.1. Market Size & Forecast
        • 7.4.4.1.1. By Value
      • 7.4.4.2. Market Share & Forecast
        • 7.4.4.2.1. By Technology
        • 7.4.4.2.2. By Application
        • 7.4.4.2.3. By End-User
    • 7.4.5. Singapore Precision Medicine Market Outlook
      • 7.4.5.1. Market Size & Forecast
        • 7.4.5.1.1. By Value
      • 7.4.5.2. Market Share & Forecast
        • 7.4.5.2.1. By Technology
        • 7.4.5.2.2. By Application
        • 7.4.5.2.3. By End-User
    • 7.4.6. Australia Precision Medicine Market Outlook
      • 7.4.6.1. Market Size & Forecast
        • 7.4.6.1.1. By Value
      • 7.4.6.2. Market Share & Forecast
        • 7.4.6.2.1. By Technology
        • 7.4.6.2.2. By Application
        • 7.4.6.2.3. By End-User

8. Europe Precision Medicine Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value & Volume
  • 8.2. Market Share & Forecast
    • 8.2.1. By Technology
    • 8.2.2. By Application
    • 8.2.3. By End-User
    • 8.2.4. By Country
  • 8.3. Market Attractiveness Index
  • 8.4. Europe: Country Analysis
    • 8.4.1. France Precision Medicine Market Outlook
      • 8.4.1.1. Market Size & Forecast
        • 8.4.1.1.1. By Value
      • 8.4.1.2. Market Share & Forecast
        • 8.4.1.2.1. By Technology
        • 8.4.1.2.2. By Application
        • 8.4.1.2.3. By End-User
    • 8.4.2. Germany Precision Medicine Market Outlook
      • 8.4.2.1. Market Size & Forecast
        • 8.4.2.1.1. By Value
      • 8.4.2.2. Market Share & Forecast
        • 8.4.2.2.1. By Technology
        • 8.4.2.2.2. By Application
        • 8.4.2.2.3. By End-User
    • 8.4.3. United Kingdom Precision Medicine Market Outlook
      • 8.4.3.1. Market Size & Forecast
        • 8.4.3.1.1. By Value
      • 8.4.3.2. Market Share & Forecast
        • 8.4.3.2.1. By Technology
        • 8.4.3.2.2. By Application
        • 8.4.3.2.3. By End-User
    • 8.4.4. Italy Precision Medicine Market Outlook
      • 8.4.4.1. Market Size & Forecast
        • 8.4.4.1.1. By Value
      • 8.4.4.2. Market Share & Forecast
        • 8.4.4.2.1. By Technology
        • 8.4.4.2.2. By Application
        • 8.4.4.2.3. By End-User

9. North America Precision Medicine Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value & Volume
  • 9.2. Market Share & Forecast
    • 9.2.1. By Technology
    • 9.2.2. By Application
    • 9.2.3. By End-User
    • 9.2.4. By Country
  • 9.3. Market Attractiveness Index
  • 9.4. North America: Country Analysis
    • 9.4.1. United States Precision Medicine Market Outlook
      • 9.4.1.1. Market Size & Forecast
        • 9.4.1.1.1. By Value
      • 9.4.1.2. Market Share & Forecast
        • 9.4.1.2.1. By Technology
        • 9.4.1.2.2. By Application
        • 9.4.1.2.3. By End-User
    • 9.4.2. Mexico Precision Medicine Market Outlook
      • 9.4.2.1. Market Size & Forecast
        • 9.4.2.1.1. By Value
      • 9.4.2.2. Market Share & Forecast
        • 9.4.2.2.1. By Technology
        • 9.4.2.2.2. By Application
        • 9.4.2.2.3. By End-User
    • 9.4.3. Canada Precision Medicine Market Outlook
      • 9.4.3.1. Market Size & Forecast
        • 9.4.3.1.1. By Value
      • 9.4.3.2. Market Share & Forecast
        • 9.4.3.2.1. By Technology
        • 9.4.3.2.2. By Application
        • 9.4.3.2.3. By End-User

10. South America Precision Medicine Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value & Volume
  • 10.2. Market Share & Forecast
    • 10.2.1. By Technology
    • 10.2.2. By Application
    • 10.2.3. By End-User
    • 10.2.4. By Country
  • 10.3. Market Attractiveness Index
  • 10.4. South America: Country Analysis
    • 10.4.1. Brazil Precision Medicine Market Outlook
      • 10.4.1.1. Market Size & Forecast
        • 10.4.1.1.1. By Value
      • 10.4.1.2. Market Share & Forecast
        • 10.4.1.2.1. By Technology
        • 10.4.1.2.2. By Application
        • 10.4.1.2.3. By End-User
    • 10.4.2. Argentina Precision Medicine Market Outlook
      • 10.4.2.1. Market Size & Forecast
        • 10.4.2.1.1. By Value
      • 10.4.2.2. Market Share & Forecast
        • 10.4.2.2.1. By Technology
        • 10.4.2.2.2. By Application
        • 10.4.2.2.3. By End-User
    • 10.4.3. Colombia Precision Medicine Market Outlook
      • 10.4.3.1. Market Size & Forecast
        • 10.4.3.1.1. By Value
      • 10.4.3.2. Market Share & Forecast
        • 10.4.3.2.1. By Technology
        • 10.4.3.2.2. By Application
        • 10.4.3.2.3. By End-User

11. Middle East and Africa Precision Medicine Market Outlook

  • 11.1. Market Size & Forecast
    • 11.1.1. By Value & Volume
  • 11.2. Market Share & Forecast
    • 11.2.1. By Technology
    • 11.2.2. By Application
    • 11.2.3. By End-User
    • 11.2.4. By Country
  • 11.3. Market Attractiveness Index
  • 11.4. MEA: Country Analysis
    • 11.4.1. South Africa Precision Medicine Market Outlook
      • 11.4.1.1. Market Size & Forecast
        • 11.4.1.1.1. By Value
      • 11.4.1.2. Market Share & Forecast
        • 11.4.1.2.1. By Technology
        • 11.4.1.2.2. By Application
        • 11.4.1.2.3. By End-User
    • 11.4.2. Saudi Arabia Precision Medicine Market Outlook
      • 11.4.2.1. Market Size & Forecast
        • 11.4.2.1.1. By Value
      • 11.4.2.2. Market Share & Forecast
        • 11.4.2.2.1. By Technology
        • 11.4.2.2.2. By Application
        • 11.4.2.2.3. By End-User
    • 11.4.3. UAE Precision Medicine Market Outlook
      • 11.4.3.1. Market Size & Forecast
        • 11.4.3.1.1. By Value
      • 11.4.3.2. Market Share & Forecast
        • 11.4.3.2.1. By Technology
        • 11.4.3.2.2. By Application
        • 11.4.3.2.3. By End-User

12. Market Dynamics

  • 12.1. Drivers
  • 12.2. Challenges

13. Market Trends & Developments

14. Competitive Landscape

  • 14.1. Competition Outlook
  • 14.2. Players Profiled (Leading Companies)
    • 14.2.1. Orion Health
    • 14.2.2. 2b Precise
    • 14.2.3. Fabric Genomics
    • 14.2.4. Pfizer
    • 14.2.5. Gene 42
    • 14.2.6. IBM Watson Health
    • 14.2.7. Philips Healthcare
    • 14.2.8. Medtronic
    • 14.2.9. Nanthealth
    • 14.2.10. Navican
    • 14.2.11. N-of-One
    • 14.2.12. PierianDx
    • 14.2.13. Sunquest Information System
    • 14.2.14. Tempus
    • 14.2.15. Novartis
    • 14.2.16. Translational Software
    • 14.2.17. Biocrates Life Sciences AG
    • 14.2.18. Nanostring Technologies
    • 14.2.19. Thermo Fisher Scientific
    • 14.2.20. Quest Diagnostics Incorporated

15. Strategic Recommendations

16. About Us & Disclaimer